Rimonabant side effects

Patients taking the Sanofi-Aventis anti-obesity drug Acomplia, known generically as rimonabant, are likely to suffer rimonabant side effects such as depression and anxiety.  Another rimonabant side effect is an increased amount of  suicidal thoughts. Rimonabant -- also known by the brand name Zimulti in the United States -- is the first in a new class of drugs that switch off the same brain circuits that make people hungry when they smoke cannabis.
   A study in the British Medical Journal in November also found that people taking rimonabant would only see "modest" weight loss with many remaining significantly obese or overweight.

Rimonabant side effects
In November of 2007, Danish researchers reviewed four published studies featuring 4,100 patients and found that people taking rimonabant 20 milligrams per day were twice more likely to discontinue treatment due to depressive disorders and three times more likely to stop because of anxiety than those who received a placebo.
In addition to depression and anxiety, rimonabant side effects include dry mouth and headaches.

For more information, see anti obesity drugs and also weight loss pill home